Andrea Loreto

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Optical Coherence Tomography

Top Venues

Eye (London, England)

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Andrea Loreto, Elisa Merlini, Michael P Coleman
Programmed axon death: a promising target for treating retinal and optic nerve disorders. Eye (London, England) 38 (10) (2024)
James R Tribble, Melissa Jöe, Carmine Varricchio, Amin Otmani, Alessio Canovai, Baninia Habchi, Evangelia Daskalakis, Romanas Chaleckis, Andrea Loreto, Jonathan Gilley, Craig E Wheelock, Gauti Jóhannesson, Raymond Ching-Bong Wong, Michael P Coleman, Andrea Brancale, Pete A Williams
NMNAT2 is a druggable target to drive neuronal NAD production. Nature communications 15 (1) (2024)
Andrea Loreto, Elisa Merlini, Michael P Coleman
Programmed axon death: a promising target for treating retinal and optic nerve disorders. Eye (London, England) (2024)
James R Tribble, Melissa Jöe, Carmine Varricchio, Amin Otmani, Alessio Canovai, Baninia Habchi, Evangelia Daskalakis, Romanas Chaleckis, Andrea Loreto, Jonathan Gilley, Craig E Wheelock, Gauti Jóhannesson, Raymond Ching-Bong Wong, Michael P Coleman, Andrea Brancale, Pete A Williams
Author Correction: NMNAT2 is a druggable target to drive neuronal NAD production. Nature communications 15 (1) (2024)
James R Tribble, Melissa Jöe, Carmine Varricchio, Amin Otmani, Alessio Canovai, Baninia Habchi, Evangelia Daskalakis, Romanas Chaleckis, Andrea Loreto, Jonathan Gilley, Craig E Wheelock, Gauti Jóhannesson, Raymond Ching-Bong Wong, Michael P Coleman, Andrea Brancale, Pete A Williams
NMNAT2 is a druggable target to drive neuronal NAD production. Nature communications 15 (1) (2024)
Andrea Loreto, Elisa Merlini, Michael P Coleman
Programmed axon death: a promising target for treating retinal and optic nerve disorders. Eye (London, England) 38 (10) (2024)
James R Tribble, Melissa Jöe, Carmine Varricchio, Amin Otmani, Alessio Canovai, Baninia Habchi, Evangelia Daskalakis, Romanas Chaleckis, Andrea Loreto, Jonathan Gilley, Craig E Wheelock, Gauti Jóhannesson, Raymond Ching-Bong Wong, Michael P Coleman, Andrea Brancale, Pete A Williams
NMNAT2 is a druggable target to drive neuronal NAD production. Nature communications 15 (1) (2024)
Andrea Loreto, Elisa Merlini, Michael P Coleman
Programmed axon death: a promising target for treating retinal and optic nerve disorders. Eye (London, England) 38 (10) (2024)
Arnau Llobet Rosell, Maria Paglione, Jonathan Gilley, Magdalena Kocia, Giulia Perillo, Massimiliano Gasparrini, Lucia Cialabrini, Nadia Raffaelli, Carlo Angeletti, Giuseppe Orsomando, Pei-Hsuan Wu, Michael P Coleman, Andrea Loreto, Lukas Jakob Neukomm
The NAD + precursor NMN activates dSarm to trigger axon degeneration in Drosophila . eLife 11 (2022)
Andrea Loreto, Carlo Angeletti, Weixi Gu, Andrew Osborne, Bart Nieuwenhuis, Jonathan Gilley, Peter Arthur-Farraj, Elisa Merlini, Adolfo Amici, Zhenyao Luo, Lauren Hartley-Tassell, Thomas Ve, Laura M Desrochers, Qi Wang, Bostjan Kobe, Giuseppe Orsomando, Michael P Coleman
Neurotoxin-mediated --potent activation of the axon degeneration regulator SARM1. eLife 10 (2021)